Professional Documents
Culture Documents
Self-Aligning Monomers For Low Shrinkage, Biomedical Composites
Self-Aligning Monomers For Low Shrinkage, Biomedical Composites
2009
Isotropic Nematic
random Self-aligned
UTHSCSA Biomaterials 4
Liquid and Nematic-Liquid-
Crystal Structures
O O
R O O R
O O
n=1,5 O O n=1,5 O
O
R = H, CH3
• n=1
• 3-t-butyl 1,4-di(4-[meth]acryloxy-hexaneoxy) benzoyloxy)-
benzene
UTHSCSA Biomaterials 6
Molecular Weight is Higher
but Viscosity is Much Less
TEGDMA MW = 258
Bis-GMA
MW = 513
C6-t-butyl-dimethacrylate MW = 743
UTHSCSA Biomaterials 7
Nematic Liquid-Crystal Synthesis
O O
Ti(O Bu)4
1) HO(CH2)6OH + NO2 C OH NO2 C O(CH2)6OH +
O O
100% NO2 C O (CH2)6 OC O NO2
O
2) + K+ - O(CH2)6OH DMSO HO(CH2) O C O(CH2)6OH +
O O
HO(CH2)6 O C O(CH2)6 OC O(CH2)6 OH
>90%
a) NaOH
3) O
b) HCl 100%
HO(CH2)6 O C OH
O
4) SOCl2
Cl (CH2)6 O 90%
C Cl
C4H9 N
O O
5) + HO OH Cl(CH2)6O C O OC O(CH2)6Cl
>90% LC at RT
O O
H2O (KBr)
6) HO(CH2)6 O C O OC O(CH2)6OH
HMPA
NMP
90% LC at RT
CH3
7) CH2=C—C—Cl O O O
O CH2=C—CO(CH2)6O C O OC O(CH2)6OH
CH3
+
O O O CH3
CH2=C—CO(CH2)6O C O OC O(CH2)6OH —O—C—C=CH2
CH3 O
Polarized Light Microscopy
of LC Monomers
Oriented Nematic Isotropic State
25o C 45o C
UTHSCSA Biomaterials 9
DSC / Calorimetry:
n→i Transition Temperature
Isotropic State
> 46o C
Oriented Nematic
< 43o C
UTHSCSA Biomaterials 10
Polymerization
Shrinkage vs. Time
Unfilled Bis-GMA based resin
UTHSCSA Biomaterials 11
Mechanism of Low Shrinkage
in Liquid Crystal Monomers
UTHSCSA Biomaterials 12
Modulus (rigidity) too Low
16
unfilled Composites
12
p < 0.05
*
8 Hybride
BisGMA
based Liq Micro Liq Cryst
Cryst Fill
Modulus (GPa)
4
**
*
0
UTHSCSA Biomaterials 13
Strength too Low
160
unfilled Composites
*
120
p < 0.05
BisGMA
based
80 Liq *
Cryst Hybrid
e
40 Micro **
Flexural Strength (MPa) Fill Liq
Cryst
0
Commercial LC6diacr- Ivoclar-Tetric Vivadent's LC6diacr-
Resin
UTHSCSA Biomaterials Unfilled Heliomolar-s Tetric 14
Flexure Strength (MPa)
•Flexure Strength (MPa)
20
40
60
80
100
120
0•0
•2•0
•4•0
•6•0
•8•0
•1•0•0
•1•2•0
•1
0% •G
TE
IB
M
•2 w
0% G/ G
TT
•1 EE
IB GTE
M
0% GTE
TM w
/G
• P T
•2 10 TM •L E
0% % A LCC
I M
M
TM B1M w/ G
LC
LC
•2 PT 0%w/ TE
0% M IBLC
A
•1 IB w MM
0% 2M /
LC
0%w GT
TM
LC +
/L E
IB C
10PTM MM
% A
+ IBM
IBM
TMw
PT/ LC
MM
20
% A
TM
LC
PT
LC +
M
+
A
TMPTMA
Bis-GMA Resin Liquid Crystal Resins
TMPTMA
Add Other Monomers:
IBM = iso-bornylmethacrylate
Flexure Strength Increases
Modulus (rigidity) Increases
Bis-GMA Liquid Crystal Resins
3000
•3•0•0•0
LC
LC +
+
(MPa)
•Modulus(MPa)
2500 GTE
GTE LC
LC LC
LC +
+ IBM
IBM TMPTMA
TMPTMA
•2•5•0•0
2000
•2•0•0•0
Modulus
1500
•1•5•0•0
1000
•1•0•0•0
500
•5•0•0
0•0
E
M
20 M
A
M
A
T
CM
IB
M
IB
M
G
LC
PT
%
T
•L
TM
10
M
T
%
%
20
10
UTHSCSA Biomaterials 16
Cure Shrinkage
Remains Low
Bis-GMA based 8 vol%
Liquid-Crystal 2 vol%
Liq-Cryst + IBM 2 vol%
BUT
Cure Rate is Too
Slow!!
UTHSCSA Biomaterials 17
LCM
Cure Rateis
70%
Slow
60% Bis GMA-based
50%
Liq. Crystal
40%
30%
(% DC)
20%
10% of Conversion
Degree
0%
0 50 100 150 200 250 300
Exposure Time (seconds)
UTHSCSA Biomaterials 18
Longer exposure times are required for Liquid Crystals
to reach the same degree of cure as GTE
70%
30%
DC %
20%
10%
0%
0 50 100 150 200 250 300 20
Exposure Time (seconds)
min
UTHSCSA Biomaterials 19
Curing Systems &
Setting Mechanisms
Strategy for fast cure, low
color, color stable resins
Photoiniator System
CQ DMAEMA
Camphor- N,N-Dimethyl-
Quinone AminoEthyl
Methacrylate
+
CQ absorbs BLUE light and photosensitizes
DMAEMA to form free radicals and initiate
polymerization
UTHSCSA Biomaterials 21
Onium-ion Photoinitiator: OPPI
I+
p-octyloxy-phenyl-phenyl
iodonium hexafuoro antimonate
UTHSCSA Biomaterials 22
OPPI accelerates both LCM cure
rate & Deg. of Conversion
70%
20%
UTHSCSA Biomaterials 26
Sebacyl and Adipyl
t-butyl
O H CH 3
O O
O
O O H O
O
O
O H O O
O
O O
CH 3 H O
MW = 943
UTHSCSA Biomaterials 27
16-component Liquid
Crystal Monomer Blend
QuickTime™ and a
decompressor
are needed to see this picture.
R3, 2 O
O R 2, 2 O R4
R1 O
O O O R 3, 1 CH2
O
O
CH2 R3,2 O O O
O
R4 O R2, 1 O
n
O R 3, 1
UTHSCSA Biomaterials 28
Materials and methods
• 16-component blend was initiated with 1% CQ
and 2% DMAEMA.
• 75% 1 micron Ba-Glass filler, stored refrigerated.
• A control mixture of BisGMA 37.5% -TEGDMA
37.5% and BisEMA 25% was used for
comparison.
• Degree of conversion and initial cure rate were
measured by FTIR
• Volumetric shrinkage was measured in an Acuvol
• Transverse strength and moduli were measured
on 2 mm square beams in an Instron/MTS
UTHSCSA Biomaterials 29
Cure Contraction
UTHSCSA Biomaterials 30
Cure Characteristics
P=0.001
P=0.022
UTHSCSA Biomaterials 31
Mechanical
Properties
Stress (MPa)
90
80
F
70
60
50
40
O
Y
SAMT
SAMT exhibits
exhibits aa high
high
30
degree
degree ofof shear
shear
M
yielding
yielding even
even at
at high
high
20 crosslink
crosslink density
density and
and
10
cure
cure
B
0
0.00 0.02 0.04 0.06 0.08 0.10 0.12 0.14 0.16
Strain (mm/mm)
UTHSCSA Biomaterials 32
Microtomed Photopolymerized SAMT Blend
& SAMT Composite (Crossed Polarizers)
Smectic L=4.58nm
Liquid Crystal
4
3.5
Before Polymerization
3
2.5
1.5
After Photopolymerizaton
0.5
4.4 nm
0
Courtesy: S. Swinnea, UT Austin
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
2 theta
UTHSCSA Biomaterials 34
Results
SAMT liquid crystal monomer blend:
Composite does not crystallize
Stable > 3 years Refrigerated
• In presence of high filler loading
Shrinkage reduced by ~75%
Mechanical properties ~ current resins
Cure rate ~ current dental resins
Blend is smectic rather than nematic
•Smectic phases remain after curing
•Light scattering --> low translucency
UTHSCSA Biomaterials 35
Biocompatibility
Studies
• LC-blend monomers and polymers
less cytotoxic than commercial
resins
• LC-blend restorative composite
utilized in ferret animal model with
no adverse effects
UTHSCSA Biomaterials 36
In Progress and Future Studies
• Synthesis simplification and scale-up.
• Eliminate smectic and phases in the
polymerized composite.
Reduce light scattering to improve esthetic
properties
• Optimize particulate-filled formulations
Nanoparticle reinforcing fillers
Characterize wear resistance
• Clinical trials
UTHSCSA Biomaterials 37
Acknowledgements
University
University of
of Texas
Texas HSC
HSC
Supported by: BK
BK Norling,
Norling, KK Whang,
Whang, Neera
Neera Satsangi,
Satsangi,VV Lee,
Lee,
NIH / NIDCR HL
HL Cardenas,
Cardenas, Q Q Whang
Whang
O O O O
R O O R
O O O O
UTHSCSA Biomaterials 40
Volumetric Shrinkage
Acuvol™ Bisco Inc.
UTHSCSA Biomaterials 42